SCHEMBL28326071

SCHEMBL28326071

O=C(Br)C(O)(c1ccccc1)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ PDE2A O00408 1/20 0.43
▸ GLA P06280 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CES2 O00748 2/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ RORC P51449 1/20 0.39
▸ RORB Q92753 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28143221 0.80 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2CES2RAB9ACYP2C9
SCHEMBL28819289 0.77 CYP2C9 (0.43) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL28960373 0.72 CYP2C9 (0.64) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL2927951 0.72 CYP2C9 (0.50) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL28957192 0.71 TAS2R14 (0.46) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL3789260 0.70 PDE2A (0.56) MEN1KMT2AALDH1A1MAPTPDE2A
SCHEMBL3172058 0.68 CES2 (0.55) MEN1KMT2AALDH1A1MAPTHTT
Bromomethane SCHEMBL3170357 0.67 MAPT (0.51) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL11599763 0.67 PDE2A (0.57) MEN1KMT2AALDH1A1MAPTPDE2A
SCHEMBL11598716 0.67 PDE2A (0.53) MEN1KMT2AALDH1A1MAPTPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106715413-B piperazine derivatives as liver X receptor modulators VITAE PHARMACEUTICALS, INC. (US) 2019-11-01 — — CN disclosed
Send feedback